Elenae Therapeutics

Curated by Signal

Develoeper of AI-based precision RNA medicines for multiple diseases

Overview

Develoeper of AI-based precision RNA medicines for multiple diseases. It offers a proprietary AI-designed antisense oligonucleotide technology to target coronaviruses, including SARS-CoV-2, aging-related diseases which include heart failure, dry age-related macular degeneration, sarcopenia, as well as rare diseases such as Duchenne and Becker muscular dystrophies.

Key facts

Founded: 2021
Headquarters: Berkeley, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Known Donor Registry
Online platform to find information on sperm and egg donors
Health TechnologySan Diego, United States
Pill Time for Family
App based solutions for pill time reminding
Health TechnologyOrlando, United States
CerpassRx
Digital platform for pharmacies and members for pharmacy benefit management
Health TechnologyThe Colony, United States

About Elenae Therapeutics

What does Elenae Therapeutics do?

Develoeper of AI-based precision RNA medicines for multiple diseases.

Where is Elenae Therapeutics headquartered?

Elenae Therapeutics is headquartered in Berkeley, United States.

When was Elenae Therapeutics founded?

Elenae Therapeutics was founded in 2021.

Which sector is Elenae Therapeutics in?

Elenae Therapeutics operates in Health Technology.

Who are Elenae Therapeutics's competitors?

Companies similar to Elenae Therapeutics include Known Donor Registry, Pill Time for Family, and CerpassRx.